View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
Sponsored by Cellular Technology Limited (CTL)

Contract Immune Monitoring and Research

Free White Paper

Contract Immune Monitoring and Research

By Cellular Technology Limited (CTL)

Contract Immune Monitoring and Research

By Cellular Technology Limited (CTL)
Enter your details to receive the free paper:

Establishing new bioanalytical laboratory assays requires a major investment of effort and capital. You can let Cellular Technology Limited’s (CTL) team of experts handle the details for you, to save time and money.

CTL has been providing contract research services to government agencies, major pharmaceutical and biotechnology companies, and academic institutions for more than 15 years. In 2007, CTL has chosen to serve as an ELISPOT reference laboratory by the Immune Tolerance Network and the Sabin Vaccine Institute’s Cancer Vaccine Consortium.

In addition, CTL has been awarded multiple infinite delivery / indefinite-quantity (IDIQ) contracts by the US National Institutes of Health (NIH) for the development and validation of human and animal models for infectious diseases and biodefense applications.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology